GHB or gamma-hydroxybutyrate is a central nervous system depressant and is a colorless liquid or a white powder. GHB is classified as a Schedule I drug in the United States, and is illegal and is not accepted for any type of medicinal use. GHB is a commonly abused club drug within the United States and is also used as a date-rape drug, which is where GHB has gotten a dangerous reputation. GHB is commonly used recreationally, but the drug is also used by addicts in combination with other drugs. Anyone with an addiction to GHB or any other drug should seek help at a substance abuse treatment center. The first step will include a drug detox program followed by an outpatient or inpatient substance abuse treatment.
Recreational Club Drug Abuse and GHB in Connecticut
GHB is a drug commonly abused by teens, young adults, and older adults within social settings and among working professionals. The drug is often mixed with alcohol to intensify the effects, but this is also dangerous and increases the risk of overdose. Some of the effects of GHB include sweating, loss of consciousness, nausea, hallucinations, amnesia, and coma. In 2002 a brand name prescription called Xyrem was approved by the Food and Drug Administration to treat narcolepsy. Xyrem is a highly regulated drug and is listed as a Schedule III controlled substance. Despite the illegal version of GHB being odorless and colorless, it does have a soapy or salty taste, which is detectable when mixed with alcohol.
Someone who takes GHB will become incapacitated due to the sedative effects. GHB also induces amnesia, and frequent user groups in the United States include high school students and college students. The drug has also been used by bodybuilders due to its protein synthesis for muscle building and reducing fat. Within the state of Connecticut, GHB is easily purchased on the streets or over the internet in liquid form or as a white powder material. The drug is typically taken orally or mixed with alcohol. According to the Connecticut State Department of Mental Health and Addiction Services (DMHAS), heroin was the most frequently reported primary drug for public treatment admissions within the state.
Heroin addiction and prescription drug abuse remain a significant problem in the communities across the state. In 2016 the state treatment providers identified heroin as the drug of choice in close to 30,000 treatment admissions. Approximately 52% of treatment admission cited heroin and other opioids as the primary drug of choice. Treatment programs in Connecticut include withdrawal management, residential treatment, and outpatient programs.